Saturday, July 11, 2026

pharma · Hypertension

Innovent Biologics

Innovent Biologics (Suzhou) is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hypertension. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to thi

Suzhou, CN HQ
2011 Founded
850 Employees
NMPA registrant Type
Company details
Clinical program

placebo

Phase 1 · mab · Healthy

placebo for Healthy is a Phase 1 program (mab) at Innovent Biologics (Suzhou) Co. with 1 ClinicalTrials.gov record(s).

Internal code CIBI311A101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Innovent Biologics (Suzhou) Co.
Phase
Phase 1
Modality
mab
Indication
Healthy
Status
completed
Trials
1